Bryan Do

436 total citations
7 papers, 288 citations indexed

About

Bryan Do is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bryan Do has authored 7 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Bryan Do's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Bryan Do is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Bryan Do collaborates with scholars based in United States, Australia and New Zealand. Bryan Do's co-authors include Sattva S. Neelapu, Sandra B. Horowitz, Loretta J. Nastoupil, Jason R. Westin, Maria Alma Rodriguez, Elizabeth J. Shpall, Paolo Strati, Sairah Ahmed, Catherine M. Claussen and Anne Rain Brown and has published in prestigious journals such as Cancer, British Journal of Haematology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Bryan Do

7 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan Do United States	6	187	79	63	53	52	7	288
Matthew L. Ulrickson United States	8	313 1.7×	156 2.0×	47 0.7×	65 1.2×	70 1.3×	35	401
Alessandro Crotta United States	7	273 1.5×	121 1.5×	28 0.4×	55 1.0×	50 1.0×	26	369
Sandra B. Horowitz United States	9	227 1.2×	43 0.5×	19 0.3×	65 1.2×	21 0.4×	14	305
S. Schuster United States	6	199 1.1×	124 1.6×	50 0.8×	123 2.3×	36 0.7×	11	330
Cyrus Khan United States	11	181 1.0×	151 1.9×	27 0.4×	28 0.5×	50 1.0×	44	275
Allison Winter United States	8	117 0.6×	100 1.3×	24 0.4×	26 0.5×	67 1.3×	39	221
Diane Baniewicz United States	12	388 2.1×	22 0.3×	50 0.8×	87 1.6×	18 0.3×	16	495
Dena DeMarco United States	7	302 1.6×	224 2.8×	20 0.3×	80 1.5×	74 1.4×	13	344
Elizabeth Budde United States	9	161 0.9×	63 0.8×	10 0.2×	48 0.9×	38 0.7×	26	275
Francesca Alt Germany	6	153 0.8×	17 0.2×	24 0.4×	42 0.8×	22 0.4×	12	257

Countries citing papers authored by Bryan Do

Since Specialization

Citations

This map shows the geographic impact of Bryan Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Do more than expected).

Fields of papers citing papers by Bryan Do

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Do. The network helps show where Bryan Do may publish in the future.

Co-authorship network of co-authors of Bryan Do

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Do. A scholar is included among the top collaborators of Bryan Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Do. Bryan Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Do, Bryan, et al.. (2024). Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma. Journal of Oncology Pharmacy Practice. 31(2). 230–235. 1 indexed citations

2.

Strati, Paolo, Sairah Ahmed, Partow Kebriaei, et al.. (2020). Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma. Blood Advances. 4(13). 3123–3127. 122 indexed citations

3.

Lewis, Katharine L., John Casey, Nada Hamad, et al.. (2020). Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. British Journal of Haematology. 192(6). 1049–1053. 31 indexed citations

4.

Buege, Michael J., Bryan Do, Hans C. Lee, et al.. (2019). Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma. Cancer Treatment and Research Communications. 21. 100159–100159. 13 indexed citations

5.

Do, Bryan, et al.. (2017). Chimeric Antigen Receptor T Cells in Hematologic Malignancies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(3). 334–345. 48 indexed citations

6.

Chihara, Dai, Jason R. Westin, Yasuhiro Oki, et al.. (2016). Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma. Cancer. 122(20). 3145–3151. 56 indexed citations

7.

Do, Bryan, et al.. (2016). Idelalisib for treatment of B-cell malignancies. American Journal of Health-System Pharmacy. 73(8). 547–555. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact